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A STUDY OF TOPICAL THERAPY IN TINEA CAPITIS*
MAURICE SULLIVAN, M.D., AND EUGENE S. BERESTON, M.D.
Thirteen treatment agents (Table 1) were evaluated in eight huiidred eighty-
one clinical trials in 460 patients (Table 2). Prior to treatment fluorescence in
infected areas was detected with the Wood's Light and cultures of fluorescent
hair were made; 83.2% were positive for M. audouini, 1.0% were positive for
M. lanosum and 15.7% showed rio growth or were contaminated. Each compound
was used for at least three months before it was considered ineffective. Medica-
tion was applied twice a day and hair was clipped once a week. Manual epilation
was not allowed. Examination were made every two weeks. Cure was determined
by disappearance of fluorescence in infected areas, regrowth of normal hair and
absence of fluorescence for 90 days after termination of treatment. The results
are summarized in Table 3. The 75% cure rate in the group of 132 patients treated
with 5-chlorosalicylanilide (No. 13) indicated that this drug was superior in
this series by the method of testing. For 2 to 3 weeks preceding disappearance of
fluorescence there was a replacement of the bright shiny green color of the infected
hairs by lustreless white. Dermatitis from the ointment occurred in 4 patients
(3%) Table 3. Of the 132 patients treated with 5-chlorosalicylanilide there were
108 with positive cultures for M. audouini; data concerning this group are sum-
marized in Table 4; the cure rate was 73.1%.
DISCUSSION
Kligman and Anderson (1) contend that there is a high percent of spontaneous
cure in tinea capitis and emphasize three considerations in the evaluation of
topical therapy: 1. Spontaneous cures occur in non-inflammatory cahes after
prolonged periods ranging from 3 months to 2 years (2); 2. Complicating inflam-
matory reactions such as folliculitis and kerion formation accelerate healing (3)
(1); and 3. So-called fungistatic agents are relatively ineffective in killing the
fungus in infected hair (4) (5). It has been observed that spontaneous cure is
associated with puberty (7). There is evidence (1) that the more extensive the
area of scalp involvement, the more resistant will be the infection to topical
therapy. Cures have been reported after application of substances that are
neither fungicidal or fungistatic, such as carbowax (1) and hormones (8).
The results with 5-chlorosalicylanilide, the best of the thirteen compounds
tested, must be evaluated with consideration for the aforementioned contentions
and facts. Cures were accomplished in 8 weeks or less in 79.7%, and in less than
6 weeks in 59.7% (Table 4); 88.6% of the cured patients were less than 10 years
old. However folliculitis and kerion complicated 13.9 per cent of the cases treated
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TABLE 1
Compositions and formulae of agents evaluated in topical therapy of tinea capitis
ACTIVE INGEEDIENT
_________________ BASE FORMTLA OF ACTIVE INGREDIENT
No. Name Content
1 Propylene glycol 100% CH3(Cf13)7COOCH2
dipelargonate CH3(CH2) 7COOCH . CIL
2 Undecylenic acid 22% Carbowax CH2CH(CH2)5COOH
Zinc undecylenate 3% ICH3=CH(CH2)sCOO-I2Zn
3 Dihydrochloride 2% Carbowax (C2H3)1NCH3CHOSof 2-Dimethyl-
amino-6-(beta- N=C . N(CH3)2
diethyl-aminoe- . 2HC1
tho xy) -benzo-
thiazole
OOCCJ-L
4 Nletacresvl 80% Ethvcellulose CH1<
acetate
5 Salievlanilide 5% Carbowax CONH<>
6 Ammoniated 10% Fatty base U. S. Pliarmacopeia
Mercury
7 Undecylenic acid 22% Carbowax See Nos. 2 and 5
Zinc undecylenate 3%
Salicylanilide 5%
8 Undecylenic acid 10% Tetrachlo- See No. 2
Copper undecle- ethylene iso- [CH2CH(CH)sCOO12Cu
nate propylalco-
hol
9 Iodine 2% Solusalve 12
Sodium Iodide 2.4% NaT
10 Dibromsalicyal- 2% Carbowax (Br)2C6f12(OH) . CHO
delyde
11 Undecylenic acid 1% Emulsion base See No. 2
cetyltrimethyl CH3 (CIT2)1 5N (CH3) +
ammo nium Cl Cl
Pentachiorphe-
nate
Cl Cl
12 Hendecanoic acid 3% Carbowax See also No. 2
and its Sodium
salt
13 5-Chlorosalicyl- 3% Carbowax Cl
anilide CONH
OH
STUDY OF TOPICAL THERAPY IN TINEA CAPITIS 177
TABLE 2
Showing sex, race and age of a group of 460 children with tinea capitis
Male Female
Age in years.... l 2 3 4 5 6 7 8 9 10 11 12 13 14 ___________ ________
White Negro White Negro
No.ofpatients 1 4 1423284546 565868 5444 136 116 244 32 68
TABLE 3
FOLLICU-
LITISA,IL ARES. OF SCALr INVOLVEMENT
KIM ION
with this chlorinated product; also cure rates were proportional to extent of
scalp involvement (Table 4). The asterol ointment evaluated in this study con-
tained 2 percent of the drug. The results reported by other investigators (8) (9)
Results with 13 treatment agents in 88/ trials in 460 patients with tinea capitis
CURES FAILURES CULTURAL BINDINGS
CASES,
NUM-
BER Num-
ber vi
REACTIONS
Num-
ber °
M. M.
audou- lano-
1111 sum
1. Propylene glycol dipel-
argonate
2. Desenex
3. Asteroldihvdrochlo-
Contact
dermatitis
Num- c
her
Oi
41
24 42 33
17 41 24
58
59
FolliCuIiti5
and Kerion
Num-
ber 0
5 8.8
1 2.4
9 3 5.4
11 0 0.0
48 0
29 1
88 1
21 0
74 0
61 60
18 62
55 74
ride 103 42 40
4. Cresatiii 29 11 38
5. Salinidol 89 34 26
6. Ammoniated Mercury
Ointment IJ.S.P 46 17 37
7. Salundek 66 20 30
8. Decupryl 35 9 26
9. Diodine 109 28 25
10. Dalyde 59 12 20
11. T.C.A.P 31 5 16
12. Hendyl 84 12 14
13. Chlorosalicylanilide ... 132 99 75
14 2 2 1211.6
8 2 6.9 2 6.9
15 1 1.1 9 10.1
29
46
26
81
47
26
72
33
63
70
74
75
80
84
86
25
44
59
26
96
52
26
62
108
0 2
0 7
0 9
4 9
1 6
4
1 21
0 24
1 2.2 5 10.80 0 4 6.10 0 1 2.9
11 10.1 13 11.9
2 3.4 5 8.5
0 0 26.500 5 643 11 8.3
TABLE 4.
Cnre rate, ages, length of treatment, occurrence of folliculitis and/or kerion, area of scalp
involvement in 108 patients with cnltures positive for ill. audouini, treated with
5-chlorosalicylanilide ointment
AGES IN YEARSCURES
No %
75 73.1
FAIL-
URES
vi
29 26.0
LENGTH OF TREAT-
MENT IN WEEKS
1 2 34 5 6 7 8910111213
1 2 4 611)891210863
1222235 422211
2 4 6 8 10 12 14
70162116 7 63
14 11 4
No %
11 13.9
2 6.8
25% or 25% to 50% to
less 50% 75% 0
No % No % No'% No %
51 64.5 20 25.3 0 10.1 0
8 27.5 7 24.1 10 34.4 4 13.7
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are based on observations of the efficacy of 5 per cent Asterol Ointment. No con-
trols with unmedicated carbowax were conducted, but 6 antifungal agents (No.
2, 3, 5, 7, 10 and 15, Table 2) incorporated in carbowax produced cure rates
respectively of 41%, 42%, 26%, 30%, 20%, and 14%.
SUMMARY
Of 13 agents tested topically in tinea capitis 5-chlorosalicylanilide was tbe most
effective producing 73.1% cures in a group of 108 patients with infections caused
by M. audouini. These results should be interpreted with consideration for all
of the factors which may influence the healing of fungous infections of the scalp
(1).
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